World's 1st migraine-prevention drug approved for sale in US
US drug regulator has approved the sale of the first-ever medicine that prevents migraine, a debilitating headache which can last from hours to days, affecting nearly 15% people worldwide. Developed by pharmaceutical firms Novartis and Amgen, the medicine would be sold in the US at $575 for a monthly self-administered injection, while no sale plans for Indian markets were announced.